Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 22, 2021
Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial
L Bargetzi, C Brack, J Herrmann, et al.
Hematological Oncology
|
December 10, 2020
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland
A A Moccia, S Aeppli, S Güsewell, et al.
Leukemia
|
August 1, 2020
Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G J Ossenkoppele, D A Breems, G Stuessi, et al.
Leukemia
|
February 6, 2020
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G J Ossenkoppele, D A Breems, G Stuessi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 4, 2016
Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)
A S Allal, C Ares, P Dulguerov, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 22, 2021
Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial
L Bargetzi, C Brack, J Herrmann, et al.
Hematological Oncology
|
December 10, 2020
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland
A A Moccia, S Aeppli, S Güsewell, et al.
Leukemia
|
August 1, 2020
Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G J Ossenkoppele, D A Breems, G Stuessi, et al.
Leukemia
|
February 6, 2020
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G J Ossenkoppele, D A Breems, G Stuessi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 4, 2016
Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)
A S Allal, C Ares, P Dulguerov, et al.
Page
of 4